In summary, increased adenosine production in cancer and the TME, driven by hypoxia-induced upregulation of CD39 and CD73 enzymes, plays a crucial role in promoting tumor survival and growth through adenosine receptor signaling. The gene discussed is NT5E; the disease is neoplasm.